Biovie

Biovie

Yahoo Finance • 25 days ago

Alliance Entertainment and BioVie Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV

ORLANDO, FL / ACCESS Newswire / September 18, 2026 / RedChip Companies will air interviews with Alliance Entertainment Holding Corp. (Nasdaq:AENT) and BioVie Inc. (Nasdaq:BIVI) on the RedChip Small Stocks, Big Money™ show, a sponsored tele... Full story

Yahoo Finance • 27 days ago

Join BioVie's Exclusive Live Investor Webinar: Inside the ADDRESS-LC Phase 2 Results

BioVie CEO Cuong Do to discuss newly reported Phase 2 data showing bezisterim's potential across key Long COVID symptoms Learn why the ADDRESS-LC findings, together with recent Parkinson's data, could strengthen the case for targeting inf... Full story

Yahoo Finance • 4 months ago

Pre-Market Movers: BYAH, LXEO, ELTX Swing Big

(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday. Price swings ahead of the opening bell are being driven by clinical trial and regulatory updates, as well as trial endpoint misses. In the Green - Prem... Full story

Yahoo Finance • 11 months ago

Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9

CARSON CITY, Nev., Nov. 19, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, is pleased to inv... Full story

Yahoo Finance • last year

BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioVie Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BioVie (BIVI) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in BioVie between August 5, 2021 a... Full story

Yahoo Finance • last year

BioVie to Host Live Investor Webinar and Q&A on Oct. 8

CARSON CITY, Nev., Sept. 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, will host an inv... Full story

Yahoo Finance • last year

BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes

CARSON CITY, Nev., Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced t... Full story

Yahoo Finance • last year

Unusual volume stocks in Monday's session

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume. [unusualvolume] UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT AUUD [https://www.chartmill.com/stock/quote/AUUD/profile]... Full story

Yahoo Finance • last year

Top stock movements in today's session.

Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT MRM... Full story

Yahoo Finance • last year

Biovie stock plunges after pricing $12 million public offering

Investing.com -- Biovie Inc (NASDAQ:BIVI) stock plunged 43% after the clinical-stage biopharmaceutical company announced the pricing of a $12 million underwritten public offering. The offering consists of 6 million units priced at $2.00... Full story

Yahoo Finance • last year

These stocks are moving in today's session

Stay up-to-date with the latest market trends in the middle of the day on Friday. Explore the top gainers and losers during today's session in our detailed report. [topmovers] TOP GAINERS TICKER CHANGE COMMENT SGBX [https://w... Full story

Yahoo Finance • last year

Traders are paying attention to the gapping stocks in Friday's session.

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. [gap] TOP GAP UP STOCKS TICKER CHANGE COMMENT ORIS [http... Full story

Yahoo Finance • last year

Which stocks are moving before the opening bell on Friday?

Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMMENT ORIS [https://www.ch... Full story

Yahoo Finance • last year

BioVie stock dips on pricing $12M securities offering

BioVie (NASDAQ:BIVI [https://seekingalpha.com/symbol/BIVI]) has priced [https://seekingalpha.com/pr/20194579-biovie-inc-announces-pricing-of-12-million-public-offering]a public offering of 6 million units at $2.00 per unit, raising approxi... Full story

Yahoo Finance • last year

BioVie Inc. Announces Pricing of $12 Million Public Offering

CARSON CITY, Nev., Aug. 07, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver d... Full story

Yahoo Finance • last year

BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology

CARSON CITY, Nev., July 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders... Full story

Yahoo Finance • last year

BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors

CARSON CITY, Nev., July 22, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders... Full story

Yahoo Finance • last year

BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders ® Congress (A™RD)

CARSON CITY, Nev., June 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (BioVie or the Company), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and... Full story

Yahoo Finance • last year

BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)

CARSON CITY, Nev., June 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders... Full story

Yahoo Finance • last year

BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress

CARSON CITY, Nev., June 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders... Full story